NO20080739L - Fremgangsmater for behandling av Epileptogenese - Google Patents

Fremgangsmater for behandling av Epileptogenese

Info

Publication number
NO20080739L
NO20080739L NO20080739A NO20080739A NO20080739L NO 20080739 L NO20080739 L NO 20080739L NO 20080739 A NO20080739 A NO 20080739A NO 20080739 A NO20080739 A NO 20080739A NO 20080739 L NO20080739 L NO 20080739L
Authority
NO
Norway
Prior art keywords
group
alkyl
methods
phenyl
optionally substituted
Prior art date
Application number
NO20080739A
Other languages
English (en)
Norwegian (no)
Inventor
Boyu Zhao
Roy E Twyman
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37637731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080739(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20080739L publication Critical patent/NO20080739L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20080739A 2005-07-12 2008-02-11 Fremgangsmater for behandling av Epileptogenese NO20080739L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69862505P 2005-07-12 2005-07-12
PCT/US2006/026277 WO2007008551A2 (en) 2005-07-12 2006-07-07 Use of 2-phenyl-l, 2-ethanedi0l-(di) carbamates for treating epileptogenesis and epilepsy

Publications (1)

Publication Number Publication Date
NO20080739L true NO20080739L (no) 2008-04-10

Family

ID=37637731

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080739A NO20080739L (no) 2005-07-12 2008-02-11 Fremgangsmater for behandling av Epileptogenese

Country Status (16)

Country Link
US (1) US20070021501A1 (https=)
EP (1) EP1906946A2 (https=)
JP (1) JP2009501223A (https=)
KR (1) KR20080028485A (https=)
CN (1) CN101309680A (https=)
AR (1) AR054550A1 (https=)
AU (1) AU2006269462A1 (https=)
BR (1) BRPI0613010A2 (https=)
CA (1) CA2615127A1 (https=)
EA (1) EA200800295A1 (https=)
EC (1) ECSP088172A (https=)
IL (1) IL188728A0 (https=)
NO (1) NO20080739L (https=)
TW (1) TW200744575A (https=)
WO (1) WO2007008551A2 (https=)
ZA (1) ZA200801402B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2307035T3 (da) * 2008-05-16 2014-01-20 Nono Inc Anvendelse af en PSD-95 inhibitor ved behandlingen af epilepsi
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN109939092B (zh) * 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
HUE066912T2 (hu) * 2015-08-24 2024-09-28 Zogenix International Ltd Lennox-Gastaut szindróma kezelési eljárása fenfluramin alkalmazásával
WO2017150903A1 (en) 2016-02-29 2017-09-08 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compounds, processes for preparing them and their uses
US20190022166A1 (en) * 2017-07-18 2019-01-24 Creative Bio-Peptides Inc. Oral anti-inflammatory peptides to treat epilepsy, seizures and cns disorders
USRE50630E1 (en) 2017-10-31 2025-10-14 Creative BioPeptides, Inc. Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain
CN109920550A (zh) * 2018-12-25 2019-06-21 天津大学 一种基于dMRI研究青少年肌阵挛性癫痫的方法
US11510961B2 (en) 2019-12-19 2022-11-29 Creative Bio-Peptides, Inc. Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof
CN115501344A (zh) * 2022-09-29 2022-12-23 重庆医科大学 一种铁螯合剂的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
AU3304997A (en) * 1996-05-31 1998-01-05 Southern Illinois University Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation
DK1156798T3 (da) * 1999-02-09 2003-11-03 Univ Virginia Felbamat-afledte forbindelser
US7122576B2 (en) * 2001-02-27 2006-10-17 Plata-Salaman Carlos R Carbamate compounds for use in preventing or treating bipolar disorder
ES2262801T3 (es) * 2001-02-27 2006-12-01 Ortho-Mcneil Pharmaceutical, Inc. Uso de un compuesto de carbamato para la prevencion o el tratamiento de trastorno bipolar.

Also Published As

Publication number Publication date
CN101309680A (zh) 2008-11-19
AR054550A1 (es) 2007-06-27
KR20080028485A (ko) 2008-03-31
WO2007008551A3 (en) 2008-06-19
AU2006269462A1 (en) 2007-01-18
EA200800295A1 (ru) 2008-12-30
ECSP088172A (es) 2008-03-26
ZA200801402B (en) 2009-10-28
EP1906946A2 (en) 2008-04-09
CA2615127A1 (en) 2007-01-18
TW200744575A (en) 2007-12-16
JP2009501223A (ja) 2009-01-15
IL188728A0 (en) 2008-11-03
BRPI0613010A2 (pt) 2010-12-14
US20070021501A1 (en) 2007-01-25
WO2007008551A2 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
NO20080739L (no) Fremgangsmater for behandling av Epileptogenese
NO20080738L (no) Fremgangsmater for neurobeskyttelse
NO20071921L (no) Fremgangsmater for behandling av epileptogenese og epilepsi
NO20064251L (no) Benzamidazolderivater og anvendelse derav
CO6180427A2 (es) Tratamiento de los trastornos generalizados del desarrollo
TW200635585A (en) Monocyclic substituted methanones
NO20072444L (no) Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser
AR054524A1 (es) Metodos y formas de dosificacion para reducir los efectos secundarios de compuestos de carbamato
EA200701536A1 (ru) Способы контроля интервала qt
IL157590A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
NO20091658L (no) Fremgangsmate for behandling av koleitt og vestibulaere lidelser
IL157594A0 (en) Carbamate compounds for use in preventing or treating anxiety disorders
NO20033801L (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
EA201070819A1 (ru) Соединения n-фенилимидазо[1,2-a]пиридин-2-карбоксамида, их получение и их применени в терапии
ATE555103T1 (de) Umwandlung von 2-pyrazolinen in pyrazole mithilfe von bromin
EA200700322A1 (ru) Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов
NO20040176L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
TW200701978A (en) Methods of treating epileptogenesis and epilepsy
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
CY1110672T1 (el) Χρηση των 2- φαινυλ-1,2-αιθανοδιολης- (δι) καρβαμικων για θεραπεια επιληπτογενεσης
AR035757A1 (es) Uso de carbamatos para la fabricacion de medicamentos para prevenir o tratar un trastorno bipolar

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application